Hemodialysis-associated Hemosiderosis in the Era of Erythropoiesis- stimulating Agents: A MRI Study

American Journal of Medicine

Volumn 125, Issue 10, 2012, Pages

  Rostoker, Guy ^a   Griuncelli, Mireille ^a   Loridon, Christelle ^a   Couprie, Renaud ^a   Benmaadi, Abbes ^a   Bounhiol, Catherine ^a   Roy, Myriam ^a   MacHado, Gabrielle ^a   Janklewicz, Phillippe ^a   Drahi, Gilles ^a   Dahan, Hervé ^a   Cohen, Yves ^a  

^a Division of Nephrology and Dialysis Hôpital Privé Claude Galien Générale de Santé   (France)

Author keywords

Hemodialysis; Hemosiderosis; Hepatic MRI; Hepcidin; Parenteral iron

Indexed keywords

BICARBONATE; C REACTIVE PROTEIN; C282Y HFE PROTEIN; FERRIC HYDROXIDE SUCROSE; HEMOGLOBIN; HEPCIDIN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PROTEIN; TRANSFERRIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALCOHOL USE DISORDER; ANEMIA; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; GENE MUTATION; HEMOCHROMATOSIS; HEMODIALYSIS; HUMAN; INFUSION; IRON OVERLOAD; IRON STORAGE; IRON THERAPY; LIVER HEMOSIDEROSIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RETICULOCYTE COUNT; RISK ASSESSMENT;

EID: 84864286737     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2012.01.015     Document Type: Article

References (38)

1. KDOQI: National Kidney Foundation 11. Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease in adults Am J Kidney Dis 47 5 Suppl. 3 2006 Sl6 S85
2. J.W. Eschbach, J.C. Egrie, M.R. Downing Correction of the anemia of end-stage renal disease with recombinant human erythropoietin Results of a combined phase I and II clinical trial N Engl J Med 316 2 1987 73 78
3. W.H. Hörl Clinical aspects of iron use in the anemia of kidney disease J Am Soc Nephrol 18 2 2007 382 393
4. K. Kalantar-Zadeh, K. Kalantar-Zadeh, G.H. Lee The fascinating but deceptive ferritin: to measure it or not to measure it in chronic kidney disease? Clin J Am Soc Nephrol 1 Suppl 1 2006 S9 S18
5. M. Ali, A.O. Fayemi, R. Rigolosi Hemosiderosis in hemodialysis patients An autopsy study of 50 cases JAMA 244 4 1980 343 345
6. T.O. Pitts, G.L. Barbour Hemosiderosis secondary to chronic parenteral iron therapy in maintenance hemodialysis patients Nephron 22 4-6 1978 316 321
7. R. Gokal, P.R. Millard, D.J. Weatherall Iron metabolism in haemodialysis patients A study of the management of iron therapy and overload Q J Med 48 191 1979 369 391
8. J. Himmelfarb Iron regulation J Am Soc Nephrol 18 2 2007 379 381
9. F. Locatelli, A. Covic, K.U. Eckardt Anaemia management in patients with chronic kidney disease: a position statement by the Anaemia Working Group of European Renal Best Practice (ERBP) Nephrol Dial Transplant 24 2 2009 348 354
10. S. Fishbane Upper limit of serum ferritin: misinterpretation of the 2006 KDOQI anemia guidelines Semin Dial 21 3 2008 217 220
11. E. Angelucci, G.M. Brittenham, C.E. McLaren Hepatic iron concentration and total body iron stores in thalassemia major N Engl J Med 343 5 2000 327 331
12. P. Brissot, M.B. Troadec, E. Bardou-Jacquet Current approach to hemochromatosis Blood Rev 22 4 2008 195 210
13. M. Ali, R. Rigolosi, A.O. Fayemi Failure of serum ferritin levels to predict bone-marrow iron content after intravenous iron-dextran therapy Lancet 1 8273 1982 652 655
14. R. Fischer, P.R. Harmatz Non-invasive assessment of tissue iron overload Hematology Am Soc Hematol Educ Program 2009 215 221
15. J.M. Alustiza, A. Casteilla, M. De Juan Iron overload in the liver: diagnostic and quantification Eur J Radiol 61 2007 499 506
16. Y. Gandon, D. Olivié, D. Guyader Non-invasive assessment of hepatic iron stores by MRI Lancet 363 9406 2004 357 362
17. E. Angelucci, G. Barosi, C. Camaschella Italian Society of Hematology practice guidelines for the management of iron overload in thalassemia major and related disorders Haematologica 93 5 2008 741 752
18. C. Canavese, D. Bergamo, G. Ciccione Validation of serum ferritin values by magnetic susceptometry in predicting iron overload in dialysis patients Kidney Int 65 3 2004 1091 1098
19. S. Fishbane, N. Miyawaki, N. Masani Hepatic iron in hemodialysis patients Kidney Int 66 4 2004 1714 1715
20. A. Baumelou, L. Mercadal, B. Canaud Traitement de l'anémie au cours de l'insuffisance rénale chronique de l'adulte Recommandations de bonne pratique Mai 2005 Agence Française de Sécurité Sanitaire des Produits de Santé http://www.afssaps.fr
21. R. Moirand, A.M. Mortaji, O. Loreal A new syndrome of liver iron overload with normal transferrin saturation Lancet 349 9045 1997 95 97
22. K.A. Bradley, K.R. Bush, M.B. McDonnel Screening of problem drinking: comparison of CAGE and Audit J Gen Intern Med 13 6 1998 379 388
23. J. Liu, Z. Huang, D.T. Gilbertson An improved comorbidity index for outcome analyses among dialysis patients Kidney Int 77 2 2010 141 151
24. th ed. 2007 Chapman and Hall, Taylor and Francis Group Boca Raton, FL
25. P. Ferrari, H. Kulkami, S. Dheda Serum iron markers are inadequate for guiding iron repletion in chronic kidney disease Clin J Am Soc Nephrol 6 2011 77 83
26. M.C. Brown, D. Gaffney, C. Gemmell Hemochromatosis gene mutations and treatment of anemia in patients on hemodialysis Hemodialysis Int 13 4 2009 460 466
27. S. Bottomley Secondary iron overload disorders Semin Hematol 35 1 1998 77 86
28. J. Várkonyi, G. Tarkovács, I. Karádi High incidence of hemochromatosis gene mutations in the myelodysplastic syndrome: the Budapest Study on 50 patients Acta Haematol 109 2003 64 67
29. P.B. Walter, E.B. Fung, D.W. Killilea Oxydative stress and inflammation in iron-overload patients with beta-thalassemia or sickle cell disease Br J Haematol 135 2006 254 263
30. N.R. Ghugre, I. Gonzalez-Gomez, E. Butensky Patterns of hepatic iron distribution in patients with chronically transfused thalassemia and sickle cell disease Am J Hematol 84 2009 480 483
31. Y. Kohgo, K. Ikuta, T. Ohtake Body iron metabolism and pathophysiology of iron overload Int J Hematol 88 1 2008 7 15
32. H. Gaenzer, P. Marschang, W. Sturm Association between increased iron stores and impaired endothelial function in patients with hereditary hemochromatosis J Am Coll Cardiol 40 2002 2189 2194
33. T. Drüeke, V. Witko-Sarsat, Z. Massy Iron therapy, advanced oxidation protein products and carotid artery intima-media thickness in end-stage renal disease Circulation 106 2002 2212 2217
34. K.A. Reis, G. Guz, H. Ozdemir Intravenous iron therapy as a possible risk factor for atherosclerosis in end-stage renal disease Int Heart J 46 2005 255 264
35. P. Van Buren, R.L. Velez, N.D. Vaziri, X.J. Zhou Iron overdose: a contributor to adverse outcomes in randomized trials of anemia correction in CKD Int Urol Nephrol 2011 Jul 10 [Epub ahead of print]
36. H.N. Ibrahim, R.N. Foley, R. Zhang, D.T. Gilbertson, A.J. Collins Parenteral iron use: possible contribution to exceeding target hemoglobin in hemodialysis patients Clin J Am Soc Nephrol 4 2009 623 629
37. A. Besarab, D. Coyne Iron supplementation to treat anemia in patients with chronic kidney disease Nat Rev Nephrol 6 2010 699 710
38. M. Morena, S. Delbosc, A.M. Dupuy, B. Canaud, J.P. Cristol Overproduction of reactive oxygen species in end-stage renal disease patients: a potential component of hemodialysis-associated inflammation Hemodial Int 9 1 2005 37 46